C

Calder Biosciences, Inc.

7 employees

Creating next-generation vaccines to protect against infection

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Respiratory Diseases

Maternal Vaccines

Subunit Protein

SARS-CoV2

Pre-Clinical

Universal Influenza

Biopharma

Health Care

RSV Vaccine

Vaccines for Old Adults

BioPharma

Antigens

Protein Science

immunogens

DS-Cav1

Vaccine

Clinical

HIV

EBV

Pathogens

Virus

Date founded

2018

Funding rounds raised

Total raised

$600K

from 4 investors over 4 rounds

C

Calder Biosciences, Inc. raised undisclosed on April 6, 2023

Investors: IndieBio and SOSV - The Accelerator VC

C

Calder Biosciences, Inc. raised $600K on July 5, 2018

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

C

Calder Biosciences, Inc. raised $99K on July 2, 2016